T-PEMF Headband Stimulation for Patients With Moderate to Servere Depression

Mental Health Services in the Capital Region, Denmark

Status: Enrolling

Conditions: Recurrent Depressive Disorder, Current Episode Severe Without Psychotic Symptoms; Moderate Depression; Recurrent Depressive Disorder, Current Episode Moderate; Severe Depressive Episode Without Psychotic Symptoms

Treatments: Device: Inactive treatment with MoodHeadBand (Placebo); Device: Treatment with MoodHeadBand (T-PEMF treatment)

Study type: Interventional

Funder types: Other

Identifiers

NCT06005103

2215332

Details and patient eligibility

About

An 8-week, two-armed, randomized-controlled trial that examines the antidepressant effect of treatment with transcranial pulsed electromagnetic fields (T-PEMF) in patients diagnosed with moderate to severe depressionusing using a new device, the MoodHeadBand (MHB).

The participants will use an active or placebo MHB for 30 minutes daily for 8 weeks.

Additionally, the following research questions will be answered:

1. If the time to respond to treatment differ between the active treatment and sham group
2. If there is a positive effect on the patients' emotional and non-emotional cognition after 8 weeks of active treatment compared to the sham group and if possible early changes in the emotional cognition can predict the treatment response after 8 weeks of treatment.
3. If the T-PEMF treatment provides improvement in restorative sleep after 8 weeks of treatment

Full description

The purpose of this study is to clarify whether daily treatment over eight weeks with weak pulsating electromagnetic fields (T-PEMF) can achieve a safe effect on depression compared to the same treatment with a placebo T-PEMF. The study will furthermore explore possible effects on cognition and the hypothesized sleep-ameliorating effect of T-PEMF. Previous Danish studies have shown a significant antidepressant effect of other T-PEMF devices in the treatment of patients with depression.

The study is designed as a blinded, randomized study where active treatment is compared with inactive (placebo) treatment. At the same time, possible side effects in the use of the headband (MoodHeadBand, MHB) are investigated.

The project was initiated June 2024. Patients consecutively referred are asked after an initial interview whether they wish to participate in the study. If they give informed consent to this, they will be randomized to active or placebo treatment. The treatment itself takes place at home, 30 minutes once a day, for 8 weeks. "Treatment as usual" takes place in parallel to the study treatment, and consists of psychotherapy in a group or individually and antidepressive medications. Follow-ups will be conducted weekly either as visits at the clinic, via videocall or as telephone calls. The participants will receive weekly surveys they are encouraged to fill out prior to the weekly follow-ups. The severity of the depression, including its symptomatology will be examined weekly during the study, the cognitive test-battery is applied at baseline, week 1 and at the final visit, the patients sleep-pattern and possible disturbances are examined via the weekly surverys.

No significant side effects have been registered when using the same type of magnetic field treatment in the previous Danish studies. It has also been shown that it is possible to carry out the treatment at home without significant problems.

Enrollment: 101 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Meeting the diagnostic criteria for moderate to severe depressive episode without psychotic symptoms according to the International Classification of Diseases and Related Health Problems 10th Revision (ICD-10)(The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993).
• Female participants: Females in the fertile age must deliver a negative pregnancy test, or previously have been sterilized.
• Female fertile participants: They must use safe contraceptive methods to be included in the study, and during the whole study.
• Has given written, informed consent to the trial.

Exclusion criteria

• Inability to speak or understand the Danish language.
• A current high risk of suicide (a score of 2 or more on the HAM-D-17 item 3).
• A co-morbid substance dependence.
• Bipolar affective disorder.
• Psychotic illness.
• Dementia.
• Other diagnoses of organic brain disease.
• The participant has any kind of implant, e.g. pacemakers or cochlear implants.
• Female participants: Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

101 participants in 2 patient groups

(A) Patients diagnosed with moderate to severe depression without psychotic symptoms

Experimental group

Description:

In total, 40 patients will be allocated to this arm. (In total, 101 patients will be included in the study. Data for the initial 21 patients included in the study could not be used to assess the antidepressant effect, why an increased number of participants was needed to secure the power for the trial. The technical difficulties have been addressed)

Treatment:

Device: Treatment with MoodHeadBand (T-PEMF treatment)

(B) Patients diagnosed with moderate to severe depression without psychotic symptoms

Sham Comparator group

Description:

In total, 40 patients will be allocated to this arm. (In total, 101 patients will be included in the study. Data for the initial 21 patients included in the study could not be used to assess the antidepressant effect, why an increased number of participants was needed to secure the power for the trial. The technical difficulties have been addressed)

Treatment:

Device: Inactive treatment with MoodHeadBand (Placebo)